Specify a stock or a cryptocurrency in the search bar to get a summary
FibroBiologics, Inc. Common Stock
FBLGFibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. It holds 150+ U.S. and internationally issued patents/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, reversing organ involution, and cancer. FibroBiologics, Inc. was incorporated in 2021 and is based in Houston, Texas. Address: 455 East Medical Center Boulevard, Houston, TX, United States, 77598
Analytics
WallStreet Target Price
13.5 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures FBLG
Dividend Analytics FBLG
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History FBLG
Stock Valuation FBLG
Financials FBLG
Results | 2019 | Dynamics |